Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
64.4M
-
Number of holders
-
168
-
Total 13F shares, excl. options
-
65.1M
-
Shares change
-
+237K
-
Total reported value, excl. options
-
$465M
-
Value change
-
+$2.63M
-
Put/Call ratio
-
5.18
-
Number of buys
-
82
-
Number of sells
-
-72
-
Price
-
$7.14
Significant Holders of AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) as of Q2 2024
189 filings reported holding CDMO - AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share as of Q2 2024.
AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) has 168 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.1M shares
.
Largest 10 shareholders include BlackRock Inc. (5.11M shares), MILLENNIUM MANAGEMENT LLC (5.1M shares), VANGUARD GROUP INC (3.8M shares), 12 West Capital Management LP (3.65M shares), AltraVue Capital, LLC (3.4M shares), STATE STREET CORP (3.33M shares), PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (2.92M shares), Royal Bank of Canada (2.87M shares), Point72 Asset Management, L.P. (2.67M shares), and PALISADE CAPITAL MANAGEMENT, LP (2.11M shares).
This table shows the top 168 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.